a) Polypharmacy is associated with the risk of bleeding in elderly
patients with venous thromboembolism (W. Leiss, Bern)
b) Suboptimal adherence to initial antithrombotic processes of care in
elderly patients with venous thromboembolism (A. Stuck,
Bern)
c) Risk of falls and major bleeding in elderly patients with venous
thromboembolism receiving anticoagulants (P. Kämpfen,
Bern)
d) Inflammatory biomarkers CCN1, FAP, and CRP in patients with
unprovoked VTE in SWITCO65+ (M. Husmann, Zürich)
e) Inflammatory biomarkers CRP, CCN1 and FAP for risk stratification of
VTE recurrence in SWITCO65+ (R. Klingenberg, Zürich)
f) Prospective comparison of prognostics biomarkers (HsTNT, proBNP,
cystatinC) in elderly patients with pulmonary embolism (N. Vuillemier and M.
Righini, Genève)
Prospective validation of the Bleeding Risk Index in elderly patients
with acute venous thromboembolism (Abstract FM236) N. Scherz, M. Méan
Pascual, K. Jäger, B. Frauchiger, M. Egloff, J. Osterwalder, N. Kucher,
CM Matter, M. Husmann, M. Aschwanden, A. Angelillo-Scherrer, N.
Rodondi, J. Cornuz, JH Beer, M. Banyai, L. Mazzolai, B. Lämmle, O.
Hugli, S. Trelle, M. Righini, D. Aujesky. Swiss Medical Forum 2011 May
4; 11(Suppl. 55):14S. Prospective comparison of clinical prognostic scores in elderly patients with pulmonary embolism. Zwierzina D, Limacher A, Méan M, Righini M, Jaeger K, Beer HJ, Frauchiger B, Osterwalder J, Kucher N, Matter CM, Banyai M, Angelillo-Scherrer A, Lämmle B, Egloff M, Aschwanden M, Mazzolai L, Hugli O, Husmann M, Bounameaux H, Cornuz J, Rodondi N, Aujesky D.
|